Life Extension Update
Friday, January 6, 2012. Although the incidence of cancer in the U.S. declined by only 0.6 percent per year in men and not at all in women between 2004 and 2008, men and women's deaths from the disease were down by 1.8 percent and 1.6 percent, according to a report published online this month in CA: A Cancer Journal for Clinicians. The American Cancer Society's annual cancer statistics report, titled Cancer Statistics 2012, notes that, with the exception of indigenous Americans, cancer death rates have decreased in every racial and ethnic group in the United States over the past decade, resulting in over a million people avoiding death from the disease during this period. While African American men have a 15 percent higher incidence of cancer compared to Caucasian men and a 33 percent higher death rate from the disease, the most rapid declines in cancer death occurred among men of African and Hispanic heritage. Lung cancer accounted for nearly 40 percent of the total decline in men's cancer death rates and breast cancer accounted for 34 percent of the decline in women. Although African Americans and Caucasians experience a higher rate of cancer and poorer survival than other groups, the other groups were observed to have a greater incidence of cancers related to infectious agents, such as human papilloma virus (HPV)-induced cervical cancer.
A standard feature of the annual report's accompanying consumer publication Cancer Facts & Figures, is its Special Section, which focuses this year on the increase that has occurred in some cancers, including melanoma and cancers of the pancreas, liver, thyroid and kidney, in addition to esophageal adenocarcinoma and oropharyngeal cancers associated with HPV. When incidence rates were examined by age, the increase was greatest for liver and HPV-related oropharyngeal cancers for men and women between the ages 55 to 64 years, and for melanoma, the greatest increase occurred among those aged 65 years and older. The authors suggest that obesity and increased detection rates could play a role in the increase of these malignancies.
Data on cancer incidence is provided by the North American Association of Central Cancer Registries, and mortality data from the National Center for Health Statistics. The report predicts 1,638,910 new cases of cancer and 577,190 deaths from the disease for 2012. The authors of the report caution that these estimates are based on statistical models, and may over- or underestimate cancer incidence and deaths. Nevertheless, the figures will prove useful to U.S. public health officials in their readiness to combat this devastating illness during the coming year.
†This supplement should be taken in conjunction with a healthy diet and regular exercise program. Results may vary.
Integra-Lean® Irvingia is protected by U.S. Patent No. 7,537,790. Other patents pending.
This supplement should be taken in conjunction with a healthy diet and regular exercise program. Individual results are not guaranteed and results may vary.
The information provided on this site is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional or any information contained on or in any product label or packaging. You should not use the information on this site for diagnosis or treatment of any health problem or for prescription of any medication or other treatment. You should consult with a healthcare professional before starting any diet, exercise or supplementation program, before taking any medication, or if you have or suspect you might have a health problem. You should not stop taking any medication without first consulting your physician.
If you are not 100% satisfied with any purchase made directly from Life Extension®, just return your purchase within 12 months of original purchase date and we will either replace the product for you, credit your original payment method or credit your Life Extension account for the full amount of the original purchase price (less shipping and handling).
These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure, or prevent any disease.